Literature DB >> 17116006

Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study.

M Eliasson1, U Janlert, J-H Jansson, B Stegmayr.   

Abstract

OBJECTIVES: To explore time trends in population total cholesterol. DESIGN AND
SETTING: Five population-based cross-sectional surveys, 1986-2004 in the northern Sweden MONICA study included 8827 men and women.
RESULTS: Age-adjusted cholesterol level declined in men, 25-64 years old, from 6.38 to 5.78 mmol L(-1) and in women from 6.32 to 5.51 mmol L(-1). Between 1994 and 2004, subjects 65-74 years old were included, and their levels also decreased, in men from 6.35 to 5.76 mmol L(-1) and in women from 7.11 to 6.24 mmol L(-1). The decrease was continuous over surveys and age groups, except in young and middle-aged men where no further decline was found after 1999. Cohorts born 1920-1939 showed decreased cholesterol over the period, whilst no change was noted for those born thereafter. In 2004, one-fourth of men and one-third of women 25-74 years achieved levels below 5.0 mmol L(-1). Subjects with low educational level, body mass index > or =25 or smokers all had higher cholesterol levels which persisted during the 18-year period. In 2004, the 9% who used lipid-lowering drugs are estimated to contribute, at most, to 0.13 mmol L(-1) lower cholesterol in the population.
CONCLUSION: Large decreases in cholesterol levels occurred in the 18-year period. Less smoking may contribute to, and increasing obesity attenuate, this trend whilst lipid-lowering drugs have had little effect until recently. Socio-economic inequalities persist.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116006     DOI: 10.1111/j.1365-2796.2006.01730.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  27 in total

1.  Recommended drug use after acute myocardial infarction by migration status and education level.

Authors:  Dashti Ali Mustafa Dzayee; Tahereh Moradi; Omid Beiki; Lars Alfredsson; Rickard Ljung
Journal:  Eur J Clin Pharmacol       Date:  2015-02-28       Impact factor: 2.953

2.  Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden.

Authors:  G Ringbäck Weitoft; O Ericsson; E Löfroth; M Rosén
Journal:  Eur J Clin Pharmacol       Date:  2008-01-06       Impact factor: 2.953

3.  Evolution of cardiovascular risk factors among 18-year-old males in Austria between 1986 and 2005.

Authors:  Astrid Wallner; Alexandra Hirz; Edith Schober; Harald Harbich; Thomas Waldhoer
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

4.  Trend in prevalence of uncontrolled total serum cholesterol for cardio-cerebro-vascular disease in a mediterranean area, 1988/89-2008/09.

Authors:  Vincenzo Capuano; Norman Lamaida; Ernesto Capuano; Maria Immacolata Borrelli; Rocco Capuano; Elisabetta Notari; Anna Grazia Iannone; Federica Marchese; Matteo Sonderegger; Eduardo Capuano
Journal:  World J Cardiol       Date:  2013-11-26

5.  Novel genetic loci associated with long-term deterioration in blood lipid concentrations and coronary artery disease in European adults.

Authors:  Tibor V Varga; Azra Kurbasic; Mattias Aine; Pontus Eriksson; Ashfaq Ali; George Hindy; Stefan Gustafsson; Jian'an Luan; Dmitry Shungin; Yan Chen; Christina-Alexandra Schulz; Peter M Nilsson; Göran Hallmans; Inês Barroso; Panos Deloukas; Claudia Langenberg; Robert A Scott; Nicholas J Wareham; Lars Lind; Erik Ingelsson; Olle Melander; Marju Orho-Melander; Frida Renström; Paul W Franks
Journal:  Int J Epidemiol       Date:  2017-08-01       Impact factor: 7.196

6.  Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: a focus on prevention strategies and treatment coverage.

Authors:  Sina Azadnajafabad; Maryam Karimian; Shahin Roshani; Negar Rezaei; Esmaeil Mohammadi; Sahar Saeedi Moghaddam; Erfan Ghasemi; Fatemeh Sadeghi Morasa; Nazila Rezaei; Arya Aminorroaya; Ali Ghanbari; Maryam Nasserinejad; Fateme Gorgani; Bagher Larijani; Farshad Farzadfar
Journal:  J Diabetes Metab Disord       Date:  2020-11-10

7.  Trends in absolute and relative educational inequalities in four modifiable ischaemic heart disease risk factors: repeated cross-sectional surveys from the Nord-Trøndelag Health Study (HUNT) 1984-2008.

Authors:  Linda Ernstsen; Bjørn Heine Strand; Sara Marie Nilsen; Geir Arild Espnes; Steinar Krokstad
Journal:  BMC Public Health       Date:  2012-04-03       Impact factor: 3.295

8.  Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden.

Authors:  Ingegerd Johansson; Lena Maria Nilsson; Birgitta Stegmayr; Kurt Boman; Göran Hallmans; Anna Winkvist
Journal:  Nutr J       Date:  2012-06-11       Impact factor: 3.271

9.  End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden.

Authors:  Johan Nilsson Sommar; Maria K Svensson; Bodil M Björ; Sölve I Elmståhl; Göran Hallmans; Thomas Lundh; Staffan M I Schön; Staffan Skerfving; Ingvar A Bergdahl
Journal:  Environ Health       Date:  2013-01-23       Impact factor: 5.984

10.  Trends in total and low-density lipoprotein cholesterol among U.S. adults: contributions of changes in dietary fat intake and use of cholesterol-lowering medications.

Authors:  Earl S Ford; Simon Capewell
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.